Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 32.85
(-18.69%)
TWD 32.85
(-18.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 14.37 Million TWD | 1625.69% |
| 2022 | 833 Thousand TWD | -3.14% |
| 2021 | 860 Thousand TWD | 1031.58% |
| 2020 | 76 Thousand TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 8.9 Million TWD | -38.02% |
| 2024 Q2 | 8.9 Million TWD | 32.39% |
| 2023 Q4 | 14.37 Million TWD | 32.11% |
| 2023 FY | 14.37 Million TWD | 1625.69% |
| 2023 Q3 | 10.88 Million TWD | -27.84% |
| 2023 Q2 | 15.08 Million TWD | 23.17% |
| 2023 Q1 | 12.24 Million TWD | 1369.75% |
| 2022 Q3 | - TWD | 0.0% |
| 2022 FY | 833 Thousand TWD | -3.14% |
| 2022 Q4 | 833 Thousand TWD | 0.0% |
| 2021 FY | 860 Thousand TWD | 1031.58% |
| 2020 FY | 76 Thousand TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -939.407% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 96.431% |
| Level Biotechnology Inc. | 13.5 Million TWD | -6.466% |
| Sagittarius Life Science Corp | 13.32 Million TWD | -7.896% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 85.164% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.086% |
| GlycoNex Incorporation | 900 Thousand TWD | -1497.222% |
| VBI | - TWD | -Infinity% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 94.407% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 95.51% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -579.991% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 94.931% |
| Visgeneer Inc. | 158.6 Million TWD | 90.937% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.021% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 91.743% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -164.684% |
| Neith Corporation | 3.54 Million TWD | -305.959% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.272% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -1127.583% |
| Enimmune corporation | 45.73 Million TWD | 68.568% |
| TaiRx, Inc. | 12.28 Million TWD | -17.003% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 465.16 Million TWD | 96.91% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 75.303% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 96.328% |
| Lin BioScience, Inc. | 42.87 Million TWD | 66.471% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -9.8% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -33.127% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 87.329% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 82.587% |
| RBC Bioscience Corporation | 487.36 Million TWD | 97.05% |
| BiOptic Inc. | 93.19 Million TWD | 84.576% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -300.195% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -2571.933% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 97.891% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1552.299% |
| NaviFUS Corp. | 32.69 Million TWD | 56.03% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 96.553% |
| Sinew Pharma Inc. | 6.46 Million TWD | -122.386% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 46.997% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 92.671% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -13.997% |
| AP Biosciences Inc | 82.07 Million TWD | 82.486% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.506% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -38.501% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 90.043% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 98.998% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 96.388% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -230.156% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -80.341% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -143.727% |
| TCI GENE Inc. | 6.79 Million TWD | -111.553% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -72.818% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -49.724% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 94.649% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -34.572% |
| PharmaEngine, Inc. | 14.8 Million TWD | 2.931% |
| Savior Lifetec Corporation | 270.37 Million TWD | 94.683% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 80.753% |
| OBI Pharma, Inc. | 501.05 Million TWD | 97.131% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 57.769% |
| Acepodia, Inc. | 273.81 Million TWD | 94.75% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 29.734% |